TIGERMED releases 2025 financials, proposes RMB1.26 per-10-share dividend and seeks RMB10 billion credit line

Bulletin Express04-29

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has issued its 2025 annual circular ahead of the 2 June 2026 AGM, detailing full-year results, capital allocation plans and upcoming shareholder resolutions.

Financial highlights • Revenue rose 3.70 % to RMB6.83 billion, driven by clinical-trial related and laboratory services (+4.57 %). • Net profit attributable to shareholders fell to RMB887.90 million. • Operating cash inflow reached RMB1.12 billion; year-end cash and cash equivalents stood at RMB1.72 billion. • Total assets amounted to RMB28.36 billion, with equity of RMB24.26 billion and liabilities of RMB4.10 billion.

Capital return & share repurchase • Board proposes a cash dividend of RMB1.26 (tax-inclusive) for every 10 shares, totalling RMB107.75 million. • During 1 Jan–30 Apr 2025 the company repurchased 6.15 million A-shares for RMB308.97 million. • Combined payout (dividend plus completed buy-backs) represents 46.93 % of 2025 attributable net profit. • Shareholders will also vote on a fresh mandate allowing on-market repurchase of up to 10 % of outstanding H-shares and issuance of up to 20 % new H-shares.

Balance-sheet flexibility • Management seeks approval to secure an integrated bank credit facility of up to RMB10 billion to support 2026 liquidity needs. • The board requests authority to amend the articles of association to create vice chairman and co-president roles.

Governance & elections • Re-election of founders Dr. Ye Xiaoping (Chairman), Ms. Cao Xiaochun (General Manager) and Mr. Wen Zengyu (COO) as executive directors. • Re-election of independent directors Mr. Yuan Huagang and Ms. Liu Yuwen, and proposed appointment of Mr. Paul Siu as a new independent director. • Independent directors will each receive annual remuneration of RMB300,000; executive directors draw remuneration from management roles only. • BDO China Shu Lun Pan is nominated to continue as external auditor for 2026.

Key meeting details • AGM and H-share class meeting: 10:00 a.m., 2 June 2026, Company headquarters, Hangzhou. Shareholders on register by 2 June 2026 are eligible to vote. • Voting will be by poll; cumulative voting applies to director elections.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment